Carregant...
The Use of Vedolizumab in Patients with Concomitant Cirrhosis and Crohn’s Disease
Vedolizumab is a humanized monoclonal α4β7 integrin antibody used in patients with Crohn’s disease (CD) and ulcerative colitis (UC). Limited data are available on the use of vedolizumab in patients with concurrent cirrhosis and inflammatory bowel disease (IBD). Patients with cirrhosis are unique, as...
Guardat en:
| Publicat a: | Cureus |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Cureus
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6168050/ https://ncbi.nlm.nih.gov/pubmed/30305988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.3080 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|